Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Bomback

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
Advances in Chronic Kidney Disease|June 20, 2020
C3 Glomerulopathy: Pathogenesis and TreatmentSyeda Behjat Ahmad, Andrew S Bomback
Clinical Kidney Journal|July 5, 2021
Proposal for a more practical classification of antineutrophil cytoplasmic antibody-associated vasculitisNestor Oliva-Damaso, Andrew S Bomback
Nature Clinical Practice. Nephrology|August 25, 2007
The incidence and implications of aldosterone breakthroughAndrew S Bomback, Philip J Klemmer
Journal of the American Society of Nephrology : JASN|June 5, 2025
Real-World Data to Advance Glomerular Disease CareNatasha S Freeman, Andrew S Bomback
Journal of the American Society of Nephrology : JASN|November 6, 2010
Updates on the treatment of lupus nephritisAndrew S Bomback, Gerald B Appel
Clinical Journal of the American Society of Nephrology : CJASN|September 21, 2013
Urinary eosinophils in AIN: farewell to an old biomarker?Mark A Perazella, Andrew S Bomback
Nature Reviews. Nephrology|June 26, 2013
Glomerular disease: ANCA-associated GN--to PLEX or not to PLEX?Andrew S Bomback, Gerald B Appel
Nature Reviews. Nephrology|October 3, 2012
Pathogenesis of the C3 glomerulopathies and reclassification of MPGNAndrew S Bomback, Gerald B Appel
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2012
Increased prevalence of acute interstitial nephritis: more disease or simply more detection?Andrew S Bomback, Glen S Markowitz
Kidney International|August 1, 2012
C3 glomerulopathy: what's in a name?Vivette D D'Agati, Andrew S Bomback
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
Advances in Chronic Kidney Disease|June 20, 2020
C3 Glomerulopathy: Pathogenesis and TreatmentSyeda Behjat Ahmad, Andrew S Bomback
Clinical Kidney Journal|July 5, 2021
Proposal for a more practical classification of antineutrophil cytoplasmic antibody-associated vasculitisNestor Oliva-Damaso, Andrew S Bomback
Nature Clinical Practice. Nephrology|August 25, 2007
The incidence and implications of aldosterone breakthroughAndrew S Bomback, Philip J Klemmer
Journal of the American Society of Nephrology : JASN|June 5, 2025
Real-World Data to Advance Glomerular Disease CareNatasha S Freeman, Andrew S Bomback
Journal of the American Society of Nephrology : JASN|November 6, 2010
Updates on the treatment of lupus nephritisAndrew S Bomback, Gerald B Appel
Clinical Journal of the American Society of Nephrology : CJASN|September 21, 2013
Urinary eosinophils in AIN: farewell to an old biomarker?Mark A Perazella, Andrew S Bomback
Nature Reviews. Nephrology|June 26, 2013
Glomerular disease: ANCA-associated GN--to PLEX or not to PLEX?Andrew S Bomback, Gerald B Appel
Nature Reviews. Nephrology|October 3, 2012
Pathogenesis of the C3 glomerulopathies and reclassification of MPGNAndrew S Bomback, Gerald B Appel
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2012
Increased prevalence of acute interstitial nephritis: more disease or simply more detection?Andrew S Bomback, Glen S Markowitz
Kidney International|August 1, 2012
C3 glomerulopathy: what's in a name?Vivette D D'Agati, Andrew S Bomback
Pageof 20